Women On the Move Against Cancer (WOMAC) is pleased to announce Kia as the headline sponsor for its 2025 Fundraiser, to be held at The Kia Oval on June 17. Kia has been a long-time supporter of WOMAC, contributing vital funds towards research, treatments, awareness and care for those affected by cancer and their families. This year WOMAC is raising money for BRIGHT Cancer Care and Skcin.

BRIGHT Cancer Care focuses on research and treatment options for patients with gastrointestinal (GI) and Hepato-Pancreato-Biliary (HPB) cancers. Its work funds research projects into different treatments for these cancers and funds new equipment for surgeries, chemotherapy, immunotherapy, radiotherapy and other advanced treatments.

Skcin was set up to boost awareness of skin cancer, promote prevention methods and early detection in the UK. Skcin’s mission is to prevent people from becoming patients. The most at-risk group is 15 to 34 year-olds with 1 in 4 men affected as opposed to 1 in 5 women. The money raised by WOMAC will go towards Skcin’s education campaigns to save lives through prevention and early detection.

Tickets go on sale this week. More information about the Fundraiser and how to book tickets will be available on the WOMAC website, www.womac.co.uk.

Paul Philpott, President and CEO of Kia UK, said: “Kia is delighted to support WOMAC in its important mission and the fight against cancer. With so many affected by the disease, it’s an honour to continue to support the vital work WOMAC is doing and to help fund research, treatments, care and awareness.”

To support BRIGHT Cancer Care and Skcin please visit WOMAC’s JustGiving page to pledge as much or as little as you can. Thank you for your support. www.justgiving.com/page/womac-24-25

To discuss sponsorship opportunities for the WOMAC Fundraiser, please contact nicola.humphreys@imprimatur.co.uk

About WOMAC
Women On the Move Against Cancer is a group of female volunteers working in the automotive industry. It was established in 1979 and aims to continue the fight against cancer by supporting a variety of projects, searching for more effective treatments or improving the quality of life for cancer sufferers, their families and carers.

About Kia UK
Kia was founded in 1944 and is Korea’s oldest automobile manufacturer. Kia arrived in the UK in 1991 and has since grown to become the UK’s fourth best-selling brand in 2024, with sales in excess of 100,000 every year since 2022.

Kia offers one of the widest model ranges available in the UK, from the Picanto city car to the fully-electric EV9 seven-seater SUV. The Sportage mid-size SUV, now in its fifth-generation, is one of the UK’s best-selling cars.

Kia sells fully-electric models including the EV3, EV6, EV9 and Niro EV. Kia plans to have launched 15 EVs globally by 2027, including nine in the UK. Kia is transitioning to become a sustainable mobility solutions provider, with every model range set to include a fully electric version in the UK and Europe by 2035. In addition, Kia sells a range of plug-in hybrid (PHEV), full hybrid (HEV), mild hybrid (MHEV), petrol and diesel cars, ensuring choice for everyone.

Kia’s long-term ‘Plan S’ global business strategy aims to establish the brand as a leader across future sustainable mobility spaces. Most recently, Kia UK revealed pricing and specification for its first PBV (Platform Beyond Vehicle), the Kia PV5 – a highly flexible commercial vehicle offering best-in-class attributes, range, payload and cargo volume.

Kia is supported in the UK by an established network of 191 dealerships, while its UK headquarters are located in Walton-on-Thames in Surrey, employing around 250 people.

About BRIGHT Cancer Care
BRIGHT funds ongoing research into improving treatment options and outcomes for patients and through the purchase of new equipment for a whole range of Gastrointestinal (GI) and Hepato-Pancreato-Biliary (HPB) cancer treatments, including surgery, chemotherapy, immunotherapy, radiotherapy and other advanced treatments.

BRIGHT supports the clinical and research work of cancer specialists at St Luke’s Cancer Centre and the Hepato-Pancreato-Biliary (HPB) Surgery Unit, both based at the Royal Surrey County Hospital (RSCH) in Guildford.

For more information go to www.brightcancercare.org.uk

About Skcin
Skcin’s primary objectives are to:

• Raise awareness of skin cancer through education, promoting prevention and early detection.
• To engage higher risk target groups via bespoke educational initiatives.
• To ensure the continued development, longevity and participation in our national accreditation schemes.
• To campaign for change, make a difference and save lives.

For more information go to www.skcin.org